Fair enough. Yep, I used the word 'you' too often. I concede your point.
Proceed to Phase 3 to me looks like the only positive information. But my take is: the FDA is fine with the safety of this and many other trial agents for COVID19, and for no cost of their own are fine with many firms like AGN continuing to look for promising data. A well-powered P3 would do that. But I expect the post-March 5 announcement to be weakly worded as that's all we've seen so far out of Chris.
I hope MedChem is wrong, I hope M$ is right. My strategy is somewhere in the middle of theirs. Preserve capital, don't risk it all, don't walk away early either. Peace